Local Institution - 129 — Glens Falls, New York

Local Institution - 129 is a clinical research site located in Glens Falls, New York, United States 12801.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 129 has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glens Falls

Browse all research sites in New York · View every site in Glens Falls

• C.R.Wood Cancer Center, Glen Falls Hospital
• C.R. Wood Cancer Center, Glens Falls Hospital
• Cancer Center at Glens Falls Hospital
• C R Wood Cancer Center at Glens Falls Hospital
• Glen Falls Hospital Cancer Center
• Charles R. Wood Cancer Center at Glens Falls Hospital
• Charles R. Wood Foundation Cancer Center at Glens Falls Hospital
• Glens Falls Hospital
• Adirondack Cancer Care - Glens Falls
• Adirondack Cancer Center
• Adirondack Medical Research Center
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 129?

Local Institution - 129 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 129 conducted?

Local Institution - 129 has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Local Institution - 129 accredited by Crixeo Clinical Trials?

Local Institution - 129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.